# FDA Inspection 866046 - University of Texas MD Anderson Cancer Center - February 13, 2014

Source: https://www.keypedia.com/records/fda_inspections/university-of-texas-md-anderson-cancer-center/c8cd35f2-d1da-4b72-859c-10ecf771c8e0
Source feed: FDA_Inspections

> FDA Inspection 866046 for University of Texas MD Anderson Cancer Center on February 13, 2014. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 866046
- Company Name: University of Texas MD Anderson Cancer Center
- Inspection Date: 2014-02-13
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1255722 - 2024-11-18](https://www.keypedia.com/records/fda_inspections/university-of-texas-md-anderson-cancer-center/0bc7d141-f4f6-4b19-b272-a8d6e0017b51)
- [FDA Inspection 1255722 - 2024-11-18](https://www.keypedia.com/records/fda_inspections/university-of-texas-md-anderson-cancer-center/407a041f-aeba-4a5b-b37d-f1589c74469c)
- [FDA Inspection 1169312 - 2022-05-12](https://www.keypedia.com/records/fda_inspections/university-of-texas-md-anderson-cancer-center/78d5c113-e32a-4592-b927-233accc39dde)
- [FDA Inspection 1169312 - 2022-05-12](https://www.keypedia.com/records/fda_inspections/university-of-texas-md-anderson-cancer-center/02379e36-2c23-4424-aad6-2eea6dc77dd0)
- [FDA Inspection 1061774 - 2018-07-27](https://www.keypedia.com/records/fda_inspections/university-of-texas-md-anderson-cancer-center/16db213c-3715-47df-bb6a-ce5167895faf)

Company: https://www.keypedia.com/companies/university-of-texas-md-anderson-cancer-center/aee7392a-e5ce-4f6f-b7ff-73c661da15cb

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d